MetLife stock gained 28% past year, showing potential for further growth by 2025

From Nasdaq: 2025-01-05 21:15:14

MetLife (MET) stock has gained 28% in the past year, outperforming the S&P 500. Q3 results showed a decline in adjusted operating revenues to $17.6 billion, with earnings at $1.93 per share. Weakness in the group benefits business impacted performance. The Trefis HQ Portfolio has provided better returns with less risk than the S&P 500.

Factors supporting MET stock include a slower path to monetary easing by the U.S. Fed and potential benefits from Donald Trump’s presidency, such as lower regulatory burden and tax reductions. The company’s dividend yield growth and share buyback program could also drive gains. At $82 per share, MET is trading 5% below Trefis’ valuation estimate of $86 per share.

Returns for MET show a 28% gain in the past year compared to the S&P 500’s 23%. The Trefis Reinforced Value Portfolio has also provided strong returns. Consider investing with Trefis for market-beating portfolios and accurate price estimates.



Read more at Nasdaq: What To Expect From MetLife Stock In 2025?